CIK 0000811641
- Non-accelerated filer
- Smaller reporting company
IMMUCELL CORP /DE/
Sign in to watch- Ticker
- ICCC
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010382980
- Phone
- +1 207-878-2770
- Business address
- 56 EVERGREEN DR, PORTLAND, ME, 04103
- 4 Open-market buy Director bought 225 shares at $4.50 ($1,013)
- 4 Open-market buy Director bought 200 shares at $4.50 ($900)
- 4 Open-market buy Director bought 3,000 shares at an average $4.55 ($13,636)
- 4 Open-market buy Director bought 250 shares at $4.35 ($1,088)
- 4 Open-market buy Director bought 5,901 shares at an average $4.57 ($26,945)
- 4/A Open-market buy Director bought 750 shares at $4.10 ($3,075)
- 4 Open-market buy Director bought 750 shares at $4.10 ($3,075)
- 4 Open-market buy Director bought 700 shares at $4.30 ($3,010)
- 4 Open-market buy Director bought 4,000 shares at an average $3.59 ($14,350)
- 4 Open-market buy Director bought 1,500 shares at $3.91 ($5,865)
- 3 Insider Initial Statement of Ownership
- 4 Option exercise President and CEO acquired 1,000 shares (option exercise)
- 4 Option exercise Vice President and CSO acquired 1,000 shares (option exercise)
- 4 Other acquisition Director acquired 39,355 shares (code W)
- 4 Open-market buy Director bought 1,500 shares at an average $3.98 ($5,965)
- 4 Open-market buy Director bought 4,000 shares at an average $3.68 ($14,734)
- 4 Open-market buy Vice President and CSO bought 1,000 shares at $3.20 ($3,200)
- 4 Option exercise President and CEO acquired 1,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 13 · 256 filings